Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chest Disorder”

14,787 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 14,787 results

Early research (Phase 1)Study completedNCT06469138
What this trial is testing

Investigate 14C-bemcentinib in Healthy Male Subjects

Who this might be right for
Non-Small Cell Lung CancerMetastatic MelanomaAcute Myeloid Leukemia+5 more
BerGenBio ASA 6
Not applicableUnknownNCT02301858
What this trial is testing

Identification of Predictive and Prognostic Markers for Lung Cancer With Metastases

Who this might be right for
Lung CancerPrimary TumorMetastases
Janna Berg 100
Testing effectiveness (Phase 2)Study completedNCT01470248
What this trial is testing

Study of Arsenic Trioxide in Small Cell Lung Cancer

Who this might be right for
Lung CancerCancer of LungPulmonary Cancer+2 more
Emory University 20
Not applicableStudy completedNCT00711685
What this trial is testing

Topical Vancomycin in Prevention of Methicillin-Resistant Staphylococcal Related Mediastinitis in Patients Receiving Coronary Artery Bypass Graft

Who this might be right for
Coronary Artery Disease
Far Eastern Memorial Hospital 50
Not applicableStudy completedNCT00188890
What this trial is testing

Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers

Who this might be right for
Lung CancerMesothelioma
University Health Network, Toronto 1,452
Testing effectiveness (Phase 2)Study completedNCT00193388
What this trial is testing

Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SCRI Development Innovations, LLC 100
Testing effectiveness (Phase 2)Ended earlyNCT01471197
What this trial is testing

Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer - Non Small Cell
Bristol-Myers Squibb 9
Not applicableNot Yet RecruitingNCT07542210
What this trial is testing

Barriers and Facilitators of Persistence With Adjuvant Osimertinib

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 100
Not applicableStudy completedNCT02162082
What this trial is testing

Coronary and Structural Interventions Ulm - Coronary Chronic Total Occlusions

Who this might be right for
Coronary Artery DiseaseIschemic Heart DiseaseStable Angina
University of Ulm 198
Testing effectiveness (Phase 2)Ended earlyNCT02954523
What this trial is testing

Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations

Who this might be right for
EGFR Gene MutationNonsmall Cell Lung Cancer
Chul Kim 10
Large-scale testing (Phase 3)UnknownNCT00657423
What this trial is testing

Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Neoplasms
Xijing Hospital 80
Not applicableUnknownNCT01891123
What this trial is testing

Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy

Who this might be right for
Non-small Cell Lung CancerBreast CancerNasal Cancer
Sun Yat-sen University 300
Testing effectiveness (Phase 2)UnknownNCT02036359
What this trial is testing

Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung ca

Who this might be right for
Non-small Cell Lung Cancer(NSCLC)
National Taiwan University Hospital 76
Testing effectiveness (Phase 2)Study completedNCT01836679
What this trial is testing

Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
Chipscreen Biosciences, Ltd. 124
Testing effectiveness (Phase 2)Study completedNCT05041062
What this trial is testing

Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma

Who this might be right for
MesotheliomaPeritoneal Mesothelioma
University of Chicago 2
Testing effectiveness (Phase 2)Study completedNCT00251446
What this trial is testing

A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Veeda Oncology 70
Not applicableLooking for participantsNCT06464042
What this trial is testing

Influence of Air Quality on the Development and Progression of Premature Coronary Artery Disease

Who this might be right for
Coronary Artery Disease PrematureAngina, StableAcute Coronary Syndrome+2 more
pablo Juan-Salvadores 4,272
Not applicableStudy completedNCT04007458
What this trial is testing

Maine Lung Cancer Coalition: Using CHWs for the Annual Lung Cancer Screening Reminder

Who this might be right for
Lung Cancer
Anne Conners 396
Very early researchLooking for participantsNCT05060796
What this trial is testing

Study of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Second Affiliated Hospital of Guangzhou Medical University 11
Testing effectiveness (Phase 2)Ended earlyNCT02920996
What this trial is testing

Merestinib In Non-Small Cell Lung Cancer And Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungSolid Tumor
Dana-Farber Cancer Institute 12
Load More Results